Europace

Article	Citations
Zero-fluoroscopy trans-septal puncture and catheter ablation of a left atrial tachycardia in a pregnant woman with a prosthetic mitral valve	286
How can we assess the risk for sudden cardiac death to decide for primary prophylactic implantable cardioverter-defibrillator in patients with heart failure in 2022?	256
Atrioventricular dromotropathy: an important substrate for complete resynchronization therapy—Authors’ reply	253
Personalized subcutaneous implantable cardioverter-defibrillator sensing vectors generated by mathematical rotation increase device eligibility whilst preserving device performance	252
Administrative data confirm safety of same-day discharge following catheter ablation of atrial fibrillation: all good or is there a fly in the ointment?	185
Impact of sodium-glucose co-transporter inhibitors on cardiac autonomic function and mortality: no time to die	180
Mexiletine for recurrent ventricular tachycardia in adult patients with structural heart disease and implantable cardioverter defibrillator: an EHRA systematic review	165
Reduction in long-term mortality using remote device monitoring in a large real-world population of patients with implantable defibrillators	136
Carbon footprint of atrial fibrillation catheter ablation	115
Extraction of lumenless pacing leads from the His bundle and left bundle branch area: outcomes of the high-volume centre	103
Interpolation of electrophysiology parameters using OpenEP: technology development and clinical application	96
Magnetic resonance imaging in patients with cardiac implantable electronic devices: the RESONANCE Spanish registry	95
Clinical validation of an artificial intelligence algorithm offering automated corrected QT-interval measurements from a single lead electrocardiogram	88
Cardiac magnetic resonance to evaluate 3D ventricular substrate depth: Prognostic implications for VT ablation approach	84
Cardiac magnetic resonance - aided ventricular tachycardia substrate ablation	80
Left atrial low-voltage areas, but not volume, predict the recurrence of atrial fibrillation in repeat ablation procedures	78
Advanced vascular aging in patients with paroxysmal atrial fibrillation - Data from RACE V	78
High-density sequential mapping of repetitive atrial conduction patterns during atrial fibrillation	74
Artificial intelligence assisted QT interval measurement in 12-lead-ECGs	74
First experience of focal pulsed field ablation for premature ventricular contractions	74
The role of local impedance drop in the acute lesion efficacy during pulmonary vein isolation performed with a new contact force sensing catheter	73
Comparison between Novel and Conventional Electrocardiographic Markers of Atrial Cardiomyopathy for identification of Persons at Risk for Ischemic Stroke	70
Aggressive ablation vs. regular ablation for persistent atrial fibrillation: a multicentre real-world cohort study	69
Different predictors of AF recurrence after pulmonary vein isolation with cryoballoon and radiofrequency ablation: insights from clinical and electroanatomical mapping data of the NO-PERSAF study	69
The predictive ability of the QT response in supine-standing test for drug induced QT prolongation	67

Benefit of integrated care in patients with atrial fibrillation- a predictive heterogeneous treatment effect analysis of the ALL-IN trial	64
Pulmonary vein isolation with the novel radiofrequency balloon catheter: predictors of single-shot isolation	62
Pulsed field ablation of persistent and long-standing persistent atrial fibrillation: acute safety, efficacy and long-term outcome from a nationwide experience	59
A Bayesian meta-analysis on recurrence of atrial arrhythmia between Hybrid AF ablation and endocardial AF ablation	58
Left-sided slow pathway ablation for atrioventricular nodal reentrant tachycardia: a single center experience	55
Stiff but keeping the beat: catheter ablation for atrial fibrillation in cardiac amyloidosis and sarcoidosis	55
The effectiveness and safety of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a Belgian nationwide cohort study	52
Different approaches to atrial fibrillation ablation in heart failure patients: temporal trends and clinical outcomes	51
Discussions on implantable cardioverter defibrillator deactivation in patients receiving radiation therapy	50
Prevalence and characteristics of arrhythmias during the pregnancy	50
Impaired heart rate variability triangular index predicts stroke and systemic embolism in patients with atrial fibrillation	50
Left atrial epicardial adipose tissue: correlation to left atrial fibrosis and arrhythmia recurrence post atrial fibrillation ablation	49
Hemolysis after atrial fibrillation ablation conducted with a new point-by-point pulsed field ablation device	49
Long-term heart failure improvement after catheter ablation of persistent atrial fibrillation in heart failure with preserved, mildly reduced and reduced ejection fraction	49
Identification of a real-world clinical model associated with atrial fibrillation in a large french primary care database	48
Impact of additional pulsed field ablation in unsuccessful radiofrequency linear lesions -acute and chronic data	48
Does the rhythm have an additional effect - left atrial strain measurement in heart failure patients with HFrEF and in patients with atrial fibrillation and preserved ejection fraction	47
Ultra-high density mapping and ablation of localized microreentrant tachycardias: insight from the CHARISMA registry	47
Appropriate therapy for implantable cardioverter defibrillators used as primary versus secondary prophylaxis	46
Optical mapping and optogenetics in cardiac electrophysiology research and therapy: a state-of-the-art review	44
The link between ischaemic stroke, ischaemic heart disease, and atrial fibrillation	44
Examination of pituitary adenylate cyclase-activating polypeptide (PACAP) in patients with atrial fibrillation undergoing pulmonary vein isolation	43
Impact of pulsed-field ablation on kidney function	42
Early detection of fluid retention with a multisensory algorithm in chronic heart failure patients	41
The effect of virtual reality on anxiety reduction in supraventricular tachycardia ablation: prospective study	41
Single-chamber versus dual-chamber pacing: real world data from the German national VIDEO project	40
Imaging-derived tissue visualization guides catheter ablation of premature ventricular contractions	39
Serial arterial blood gas monitoring during deep sedation for left atrial ablation procedures: a retrospective cohort study	39
Sudden cardiac death and atrial depolarization in coronary artery disease—Authors’ reply	38
Pulsed field ablation of the left common pulmonary vein: a new single-shot solution?	38
Ablation for idiopathic ventricular arrhythmias using focal pulsed field ablation	38
CIED replacement optimization: feasibility, safety and acceptability of day surgery setting for CIED replacement	38
CRT with triple fusion: results of the multicentric, randomized, doble-blinded CRUSTY trial	38
Prevalence and risk factors of pre-procedural left atrial thrombus in patients undergoing pulmonary vein isolation	38
Extended use of preprocedural data to detect expiratory airflow limitation in patients with atrial fibrillation scheduled for ablation	38
Pre-diabetes increases the risk of heart failure among patients with nonvalvular atrial fibrillation	37
Implementation of near zero fluoroscopy in supraventricular tachycardia ablation procedures: a single center experience	37
The new "olive strategy" for pulsed field ablation of atrial fibrillation: procedural data and early follow-up	37
Volumetric quantification of epicardial fat using semiautomated atrial CT segmentation in patients with atrial fibrillation: the Prospective AFAT study	37
Preclinical evaluation of safety and efficacy of the Coherent Sine-Burst Electroporation (CSE) ablation system in a chronic porcine beating heart model	37
Genetic and clinical risk factors for stroke recurrence with different impact by assessment age: data from the UK Biobank	36
Prevalence of glucose metabolism disorders and its association with left atrial remodelling before and after catheter ablation in patients with atrial fibrillation	36
LAT velocity vectors: a novel tool for ventricular functional substrate characterization	36
LINAC-Based STereotactic Arrhythmia Radioablation (STAR) for paroxysmal atrial fibrillation in elderly: a prospective phase II trial	36
Impact of atrial fibrillation diagnosis-to-ablation time on 24-month efficacy and safety outcomes in the Cryo Global Registry	36
Early vs. delayed vt ablation in patients with ischemic cardiomyopathy	36
Conduction system pacing vs biventricular pacing in patients with left bundle branch block and resynchronization therapy indication. CONSYST-CRT trial secondary findings	35
Transvenous lead extraction: Experience of the Tandem approach	35
Innovative approaches to atrial fibrillation prediction: should polygenic scores and machine learning be implemented in clinical practice?	35
Cardioneuroablation for treatment of atrioventricular block: to cure the patient or the electrocardiogram?	34

Simplification of resetting response in slow/fast atrioventricular nodal reentrant tachycardia: the 3 catheters approach	34
Biomarkers to predict improvement of left ventricular ejection fraction after atrial fibrillation ablation	34
Atrioventricular nodal reentrant tachycardia ablation (avnrt), a female disease. insights from the german ablation registry	34
A leadless ventricular pacemaker providing atrioventricular synchronous pacing in the real-world setting: acute results from the Micra AV post-approval registry	33
The novel POLARx ablation system improves cryothermal single-shot guided pulmonary vein isolation: impact of individual pulmonary vein anatomy	33
Left bundle branch area pacing: predictors of success	33
Coronary sinus cannulation as real time anatomical landmark to facilitate left bundle branch area pacing	33
Failed shocks in hypertrophic cardiomyopathy patients: prevalence, predictors and outcome	33
Utilising the pericardial CO2 insufflation technique to facilitate endo-epicardial AF ablation, achieving linear radiofrequency lesion sets, for persistent atrial fibrillation	33
Permanent epicardial pacing : a first line strategy in children	32
New onset, recurrence and progression of atrial fibrillation after cardiac surgery during 2.5 years of continuous rhythm monitoring	32
Analysis of mitral isthmus ablation in patients undergoing a second ablation procedure after atrial fibrillation ablation with electroporation vs. radiofrequency	32
Initial heart rate score predicts new-onset atrial tachyarrhythmias in pacemaker patients	32
New insights from repeated extra-cardiac vagal nerve stimulation after recent successful cardioneuroablation in high risk patients with vagally-mediated bradyarrhythmias	32
Scar architecture determinants of ventricular arrhythmias in patients with hypertrophic cardiomyopathy: a cardiac magnetic resonance study	32
The Wolff–Parkinson–White pattern in neonates: results from a large population-based cohort study	32
Pacemaker dependency after Cox Maze procedure concomitant with cardiac surgery, The road between Scylla and Charybdis	31
Optimisation of decrementing evoked potential mapping for functional substrate identification in ischaemic ventricular tachycardia ablation	31
Effect of infarct size on the risk of ventricular arrhythmias in patients with chronic total coronary occlusion	30
Atrial endomysial fibrosis is associated with sex, atrial fibrillation, heart failure and age in cardiac surgery patients: results from the Catch-Me consortium	30
Ventricular pre-excitation in young patients: long term follow-up and natural history in a contemporary cohort	30
Manual compression versus modified figure-of-8 stitch after left atrial ablations: a comparative randomized trial	30
MicroPort CRM considerations on Vega pacing lead performance	30
Rhythm matters: sinus and pace rhythm map significantly differ in endo/epicardial 3D electroanatomic mapping	30
High efficacy and safety of endocardial pulsed electrical field ablation via contact force-controlled catheters for mitral isthmus ablation	30
Prevalence and clinical impact of major incidental findings detected on routine cardiovascular resonance imaging prior to catheter ablation of atrial fibrillation	29
Adherence to a mobile health-based atrial fibrillation screening program: a subanalysis from STROKESTOP I and II	29
Underlying reasons for sex difference in survival following out-of-hospital cardiac arrest: a mediation analysis	29
Computed tomography as a predictive tool for ventricular tachycardia	29
Late gadolinium enhancement is a strong predictor of life threatening arrhythmias in patients with non-ischemic dilated cardiomyopathy undergoing ICD implantation for primary prevention of sudden card	28
Management of modifiable risk factors and comorbidities in atrial fibrillation: suggestions for improvement from a patient perspective	27
Electromechanical factors associated with favourable outcome in cardiac resynchronization therapy	27
Long-term effects of catheter ablation versus antiarrhythmic drugs on health-related quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial revisited	27
Bipolar radiofrequency ablation of refractory ventricular arrhythmias: results from a multicentre network	27
Dynamic evaluation of atrial fibrillation risk factors using multiple sensors of implantable cardioverter defibrillators	27
Timing of stroke risk reassessment in atrial fibrillation patients with CHA2DS2-VA score of 0 or 1: the Norwegian AFNOR study	27
Anti-tachycardia pacing in ARVC: should a transvenous or subcutaneous system be used?	27
Hybrid atrial fibrillation ablation: long-term outcomes from a single-centre 10-year experience	26
Silent cerebral lesions following catheter ablation for atrial fibrillation: a state-of-the-art review	26
Antibiotic prophylaxis based on individual infective risk stratification in cardiac implantable electronic device: the PRACTICE study	26
State of the Art of Artificial Intelligence in Clinical Electrophysiology in 2025: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), an	26
Virtual pacing of a patient’s digital twin to predict left ventricular reverse remodelling after cardiac resynchronization therapy	26
Impact of left atrial appendage flow velocity on thrombus resolution and clinical outcomes in patients with atrial fibrillation and silent left atrial thrombi: insights from the LAT study	26
Association of heart failure with procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with atrial fibrillation: insights from the nat	26
Novel four-exon deletion in ryanodine receptor gene (RYR2) associated with mixed electric and structural cardiac phenotype	26
Management of ventricular tachycardia in patients with ischaemic cardiomyopathy: contemporary armamentarium	26
Clinical impact of capsulectomy during cardiac implantable electronic device generator replacement: a prospective randomized trial	26
Efficacy and safety of a novel cryoballoon ablation system: multicentre comparison of 1-year outcome	26
Prediction of occult atrial fibrillation in patients after cryptogenic stroke and transient ischaemic attack: PROACTIA	26
Electrographic flow mapping of persistent atrial fibrillation: intra- and inter-procedure reproducibility in the absence of ‘ground truth’	26
Evaluation of posterior mitral isthmus ablation in the absence of a vein of Marshall	26
Clinical impact of right ventricular pacing burden in patients with post-transcatheter aortic valve replacement permanent pacemaker implantation	25
Corrigendum to: Infanticide vs. inherited cardiac arrhythmias	25
Outcomes of percutaneous left atrial appendage occlusion device implantation in atrial fibrillation patients based on underlying stroke risk	25
EHRA perspective on the digital data revolution in arrhythmia management: insights from the association’s annual summit	25
A proteomic analysis of atrial fibrillation in a prospective longitudinal cohort (AGES-Reykjavik study)	25
Outcomes of pulmonary vein isolation with radiofrequency balloon vs. cryoballoon ablation: a multi-centric study	25
Controversy: the blanking period after atrial fibrillation ablation is needed and should be maintained	25
Lead management in patients undergoing percutaneous tricuspid valve replacement or repair: a ‘heart team’ approach	25
Late recurrence of atrial fibrillation 5 years after catheter ablation: predictors and outcome	25
EHRA expert consensus statement and practical guide on optimal implantation technique for conventional pacemakers and implantable cardioverter-defibrillators: endorsed by the Heart Rhythm Society (HRS	24
Practical Guide on Left Atrial Appendage Closure for the Non-implanting Physician. An International Consensus Paper	24
Epicardial ablation in high-risk Brugada syndrome to prevent ventricular fibrillation: results from a randomized clinical trial	24
Electroanatomic visualization of coronary arteries: a case series to elicit safety, feasibility, and diagnostic value in complex ablation procedures	24
Major in-hospital complications after catheter ablation of cardiac arrhythmias: individual case analysis of 43 031 procedures	24
Selective sparing of Purkinje fibres with pulsed-field myocardial ablation	24
The need to refine selection criteria for catheter ablation in heart failure patients with atrial fibrillation	24
How to use digital devices to detect and manage arrhythmias: an EHRA practical guide	24
2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: comment—Authors’ reply	23
Association between left atrial epicardial fat, left atrial volume, and the severity of atrial fibrillation	23
Impact of maintenance anaesthetics on total emissions of an atrial fibrillation catheter ablation procedure	23
Comprehensive comparison of stroke risk score performance: a systematic review and meta-analysis among 6 267 728 patients with atrial fibrillation	23
Current clinical practice in patients with cardiac implantable electronic devices undergoing radiotherapy: a literature review	23
The extravascular implantable cardioverter-defibrillator: characterization of anatomical parameters impacting substernal implantation and defibrillation efficacy	23
Atrial fibrillation and heart failure temporality: does it matter?	23
A comparative analysis of conduction system pacing and biventricular pacing in patients undergoing atrioventricular node ablation: a systematic review and meta-analysis	22
Apical versus septal pacing - can we chose the localization of ventricular lead in order to prevent upgrade to cardiac resynchronization therapy?	22
AV synchrony maintained by a dual-chamber leadless pacemaker in real-world conditions	22
Extraction outcomes of implantable cardioverter-defibrillator leads vary by manufacturer and model family	22
Association between amount of biventricular pacing and heart failure status measured by a multisensor implantable defibrillator algorithm	22

Impact on ganglionated plexi and arrhythmia recurrence of pulmonary vein isolation with pulsed field ablation compared to thermal energy	22
Identifying (electrophysiological) predictors of atrial fibrillation recurrences after catheter ablation: first results from the ISOLATION registry	22
Implantable cardioverter-defibrillator implantation should be considered in high-risk patients with apical hypertrophic cardiomyopathy as the same manner with the septal type	22
Non-invasive identification of deceleration zones in the atria using imageless ECGI: correlation with contact-mapping	22
Atrial fibrillation screening to prevent stroke in patients with high NT-proBNP - a post-hoc analysis of the randomized LOOP study	22
Renal denervation for the management of refractory ventricular arrhythmias	22
Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement	22
In silico biatrial fibrosis ablation improves atrial fibrillation outcome	22
First-line Marshall plan approach in persistent atrial fibrillation: a prospective single-center cohort study	22
Renal outcomes of early rhythm control in patients with atrial fibrillation and chronic kidney disease	22
Weight-loss management after catheter ablation of atrial fibrillation	22
Catheter ablation for the treatment of ventricular arrhythmias in the early phase following acute coronary syndrome	21
Increased pacemaker implantation and mortality rates in relatives of patients with early-onset sinus node dysfunction: can genetics explain all?	21
Anatomical and electrophysiological factors involved in atrial cardiomyopathy identify remodeling discrepancies between paroxysmal and persistent atrial fibrillation	21
Optimal timing of of cardiac implantable electronic device reoperation	21
Shift work and incident atrial fibrillation in younger and older individuals	21
Impact of contact force on local impedance measurements in different atrial locations	21
Use of three-dimensional electroanatomic mapping for epicardial access: needle tracking, electrographic characteristics, and clinical application	21
Genotype-phenotype correlation in hypertrophic cardiomyopathy: moving towards precision medicine?	21
How to ablate the septo-pulmonary bundle: a case-based review of percutaneous ablation strategies to achieve roof line block	21
Diagnostic accuracy of smartwatches for automated atrial fibrillation detection over time: insights from the basel wearable study	21
Long-term outcome after catheter ablation for fascicular ventricular tachycardia in a single high-volume center in Germany	20
Biatrial ablation versus left atrial ablation for atrial fibrillation treatment in patients with rheumatic heart disease undergoing valve surgery: a systematic review and meta-analysis	20
Impact of pulmonary vein anatomy and ostial dimensions on long term outcome after single-shot device guided cryoablation for paroxysmal atrial fibrillation	20
Rigorous and long-term cardiac monitoring strategy in cryptogenic stroke or TIA patients in a tertiary care centre results in a two-fold increase in AF detection	20
Septal venous channel perforation during left bundle branch area pacing: a prospective study	20
Heterogenous atrial conduction in patients with hypertrophic cardiomyopathy and atrial fibrillation	20
Exploring the effects of glucagon-like peptide-1 receptor agonists on ventricular arrhythmias: a propensity score-matched analysis	20
Pulmonary vein isolation with additional substrate ablation for atrial fibrillation results in an increased risk for the development of atypical atrial flutter	20
Re-recognized the Maintenance Mechanism of Persistent Atrial Fibrillation via Electrogram Analysis in Termination Regions	20
Cardioversion strategy impacts quality of rate control during recurrences of atrial fibrillation	20
Association between regular exercise and the risk of major adverse cardiovascular events in patients with pacemaker	20
Which paced QRS duration can be achieved in selective and non-selective His bundle pacing?	20
Deep septal pacing for pacemaker-induced cardiomyopathy	20
Age-stratified comparison of prognosis in cardiac resynchronization therapy with or without prophylactic defibrillator for nonischemic cardiomyopathy—a nationwide cohort study	20
Atrial fibrillation screening for stroke prevention: an instrumental variables meta-analysis addressing varying participation rates	20
The impact of the catheter ablation on long-term prognosis in patients with hypertrophic cardiomyopathy and atrial fibrillation	19
Usefulness of simultaneous isolation of the coronary sinus and the left atrial inferior wall for persistent atrial fibrillation refractory to box isolation	19
Non-standard approach for device selection. Left bundle branch optimized ICD for patients with heart failure and LBBB	19
Characterization and clinical significance of hemolysis after pulsed-field ablation for atrial fibrillation: insights from a multicentric analysis	19
What determines who gets cardiac resynchronization therapy in europe?	19
Additional features in Brugada Syndrome stratification: frequent PVC and QRS duration	19
Volume-weighted unipolar voltage identifies diffuse fibrosis in patients with non-ischemic cardiomyopathy	19
Weight change does not impact the long-term outcomes following pulmonary vein isolation in obese patients with atrial fibrillation	19
Three-year chronic follow-up from the pilot study of a substernal extravascular implantable cardioverter defibrillator	19
Targeted left ventricular lead positioning to the site of latest activation in cardiac resynchronization therapy: a systematic review and meta-analysis	19
Additional coils mitigate elevated defibrillation threshold in right-sided implantable cardioverter defibrillator generator placement: a simulation study	19
Optimized workflow with hybrid (very) high-power short-duration radiofrequency ablation renders point-by-point pulmonary vein isolation as fast and effective as cryoballoon ablation	19
Evidence for a shift from right ventricular to left ventricular outflow tract origin of idiopathic premature ventricular contractions with advancing age	19
Zero fluro compared to fluoroscopy guided radiofrequency ablation of typical atrial flutter	18
Prognostic significance of beat-to-beat variability of spatial heterogeneity of repolarisation analysed from 5-minute resting electrocardiogram in coronary artery disease	18
Atrial fibrillation after patent foramen ovale closure in patients with embolic stroke of undetermined source	18
An automatic single beat algorithm to discriminate farfield from nearfield bipolar voltage electrograms from the pulmonary veins	18
In-hospital mortality following catheter ablation procedures in Germany: insights from the VARY project	18
Practicing physicians perception of feasibility and usefulness of quality indicators of treatment for atrial fibrillation	18
Electrophysiologic effects of left bundle branch area pacing: comparing left ventricular septal pacing and left bundle branch pacing	18
Biophysical parameters and time to isolation of pulmonary veins with a novel cryoballoon: results of POLAR ICE study	17
Ventricular septal defect characteristics influence presence and properties of septal anatomical isthmuses in patients with repaired tetralogy of Fallot	17
First clinical experience with cardiac magnetic resonance guided typical atrial flutter ablation with the integration of active catheter tracking and electro-anatomical mapping	17
Left-bundle branch block, an alert for cardiac resynchronization therapy	17
Comparison of quality-of-life following cryoballoon versus radiofrequency catheter ablation of symptomatic atrial fibrillation - a subanalysis of the FREEZE cohort study	17
Determinants of mortality after stereotactic radio-ablation for ventricular tachycardia. Results from the international MUSIC consortium	17
Electroanatomic mapping system guided His bundle pacemaker implantation: experience of the His bundle registry graz	17
Acute procedural outcomes of left bundle branch area pacing compared to His-bundle pacing	17
In memoriam: Stuart J. Connolly, MD, 9 April 1949–2 June 2024	17
Non-invasive delineation of ventricular tachycardia substrates for cardiac stereotactic body radiotherapy: utility of in-silico pace-mapping	17
The impact of atrial fibrillation and atrial tachycardias on the hemodynamic status of patients with pulmonary hypertension	17
Zero- and minimal fluoroscopic approaches during ablation of supraventricular tachycardias: A systematic review and meta-analysis	17
Very-early detection of atrial fibrillation in patients after ablation evaluated by a home-based wearable ECG-patch	17
Pulsed electric field, cryoballoon, and radiofrequency for paroxysmal atrial fibrillation ablation: a propensity score-matched comparison	17
Genetic testing in children with Brugada syndrome: results from a large prospective registry	17
Recurrent variant of unknown significance in KCNH2 classified through functional characterisation	17
Leap or lag: left atrial appendage closure and guidelines	17
Predicting dementia in patients with atrial fibrillation using machine learning of a large multimodal registry	17
Evaluating the efficacy of pre-ablation algorithms in WPW syndrome localization: a retrospective study	17
Single-center outcome after ablation of atrial fibrillation using very high-power short duration pulmonary vein isolation	16
Novelty about pocket histology at cardiac implantable electronic device reopening procedures	16
Radiofrequency ablation to achieve durable pulmonary vein isolation	16
Combined atrial fibrillation ablation and left atrial appendage occlusion procedure in the United States: a propensity score matched analysis from 2016–2019 national readmission database	16
Ganglionated plexi ablation impact on AF mechanisms and outcomes in patients with low scar burden	16
Vascular complications of pulsed-field ablation of atrial fibrillation using a streamlined procedural workflow - when less is not more	16
Left bundle branch pacing with normal paced QRS axis produce more physiological left ventricular lateral wall depolarization than its pacing resulting in heart axis deviation	16
Prognostic impact of vascular disease in patients with atrial fibrillation: Insights from The Loire Valley Atrial Fibrillation Project	16
Combined endo- and epicardial pace-mapping to localize ventricular tachycardia isthmus in ischaemic and non-ischaemic cardiomyopathy	16
360° Virtual reality to improve patient education and reduce anxiety towards atrial fibrillation ablation	16
Myeloperoxidase as prognostic factor for atrial fibrillation development in patients with ST-segment elevation myocardial infarction	16
A novel score to predict left atrial appendage thrombus and sludge in patients with persistent atrial fibrillation on chronic anticoagulants	16
Endocardial pacing results in better electrical resynchronization and hemodynamic improvement than epicardial pacing in CRT	16
Septal flash correction with His-Purkinje pacing predicts echocardiographic response in resynchronization therapy	16
The effect of thresholding techniques on 3D quantitative scar metrics in patients with implantable cardioverter defibrillator	16
Tackling of challenging accessory pathways utilizing open window mapping, does it add benefit?	16
Ablation of anomalous mitral annular pathways via transradial access: early hospital discharge due to the covid-19 pandemic	16
Cardiac implantable electronic devices following orthotopic heart transplantation: insights on indications and outcomes from a single centre experience	16
Risk factors of mortality after secondary procedures during the world-wide randomized antibiotic envelope infection prevention trial (WRAP-IT)	16
Procedural safety, short and long-term follow up after pacemaker implantation in nonagenarians	16